medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Número 1

<< Anterior

Rev Invest Clin 2017; 69 (1)


Psoriasis in Children and Adolescents: Epidemiological Study of 280 Patients from Mexico

Tovar-Garza A, Meza-Resendiz M, Guevara-Gutiérrez E, Barrientos-García JG, Tlacuilo-Parra A

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 47-50
Archivo PDF: 145.00 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. G elfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141: 1537-41.

  2. Matusiewicz D, Koerber A, Schadendorf D, Wasem J, Neumann A. Childhood psoriasis-an analysis of German health insurance data. Pediatr Dermatol. 2014;31:8-13.

  3. Kumar B, Jain R, Sandhu K, Kaur I, Handa S. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol. 2004;43:654-8.

  4. A ugustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162:633-6.

  5. Williams K, Thomson D, Seto I, et al. StaR Child Health Group. Standard 6: Age Groups for Pediatric Trials. Pediatrics. 2012;129: 153-60. Table 3. Comparison of epidemiological studies of pediatric psoriasis Study Country n Male: female ratio Family history % Type % Nail involvement % Current study Mexico 280 1:1.5 5.0 Plaque 68.0 Guttate 12.5 Palmar-plantar 11.0 5.0 Matrix 73.0 Moustou, et al. 201416 Greece 842 1:1 16.7 Plaque 82.1 Inverse 20.2 Guttate 7.5 11.8 Fan, et al. 200713 China 277 1:1.13 34.3 Plaque 68.6 Guttate 28.9 Erythroderma 1.4 5.6 Matrix 50.0 Seyhan, et al. 20068 Turkey 61 1:1.6 23.0 Plaque 83.6 Erythroderma 16.9 21.3 Matrix 53.9 Kumar, et al. 20043 India 419 1:0.9 4.5 Plaque 60.6 Plantar 12.8 Guttate 9.7 31.0 Matrix 67.0 Morris, et al. 200114 Australia 1,262 1:1.14 71.0 Plaque 34.0 Inverse 21.6 Guttate 6.4 – Nanda, et al. 199017 India 112 1:0.9 9.8 Plaque 69.6 Guttate 25.9 Erythroderma 1.8 39.3 Matrix 76.0

  6. O besity and overweight. Center for Disease Control (CDC). Available at: https://www.cdc.gov/ncbddd/spanish/disabilityandhealth/ obesity.html [Accessed 01/12/2017].

  7. O besity and overweight. World Health Organization (WHO). Available at: http://www.who.int/mediacentre/factsheets/fs311/es/ [Accessed 01/12/2017].

  8. Seyhan M, Cos¸kun BK, Sagˇlam H, Ozcan H, Karincaogˇlu Y. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int. 2006;48:525-30.

  9. Farber EM, Mullen RH, Jacobs AH, Nall L. Infantile psoriasis: a follow up study. Pediatr Dermatol. 1986;3:237-43.

  10. Henseler T. The genetics of psoriasis. J Am Acad Dermatol. 1997; 37:1-11.

  11. Swanbeck G, Inerot A, Martinsson T, et al. Genetic counselling in psoriasis: empirical data on psoriasis among first- degree relatives of 3095 psoriatic probands. Br J Dermatol. 1997;137:939-42.

  12. Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016: 38:11-27.

  13. Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol. 2007; 21:762-5.

  14. Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18:188-98.

  15. L ysell J, Tessma M, Nikamo P, Wahlgren CF, Ståhle M. Clinical characterization at onset of childhood psoriasis - a cross sectional study in Sweden. Acta Derm Venereol. 2015;95:457-61.

  16. Moustou AE, Kakourou T, Masouri S, Alexopoulos A, Sachlas A, Antoniou C. Childhood and adolescent psoriasis in Greece: a retrospective analysis of 842 patients. Int J Dermatol. 2014;53:1447-53.

  17. N anda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an epidemiological survey of 112 patients. Pediatr Dermatol. 1990;7:19-21.

  18. Megna M, Napolitano M, Balato A, et al. Psoriasis in children: a review. Curr Pediatr Rev. 2015;11:10-26.

  19. Halverstam C, Lebwohl M. Nonstandard and off label therapies for psoriasis. Clin Dermatol. 2008;26:546-53.

  20. Balci DD, Duran N, Ozer B, Gunesacar R, Onlen Y, Yenin JZ. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol. 2009; 19:238-42.

  21. A tefi N, Noorbakhsh S, Ghavidel DS, Tabatabaei A, Rezaee M. The rise of staphylococcal super antigens in psoriatic patients: a case-control study. See comment in PubMed Commons belowJundishapur J Microbiol. 2014;7:e9912.




2020     |     www.medigraphic.com